Loading clinical trials...
Loading clinical trials...
The purpose of this study is to understand the reliability of \[18F\]-FTC-146 brain uptake in healthy controls.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Stanford University
NCT07109245 · Brain Insulin Sensitivity, Healthy Controls, and more
NCT06780917 · Mild Cognitive Impairment (MCI), Major Depressive Disorder, Remitted, and more
NCT07284290 · Dementia With Lewy Bodies, Parkinson Disease Dementia, and more
NCT07245303 · Musculoskeletal Pain, Fibromyalgia, and more
NCT06098612 · Parkinson's Disease, Multiple System Atrophy, and more
Department of Psychiatry and Behavioral Sciences
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions